Status: current, Defined. Date: 31-Aug 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5091128012 | Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 5091129016 | Leuprolide acetate 22.5 mg powder for prolonged-release suspension for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 5091130014 | Leuprorelin acetate 22.5 mg powder for prolonged-release suspension for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Leuprorelin acetate 22.5 mg powder for prolonged-release suspension for injection vial | Is a | Leuprorelin only product in parenteral dose form | true | Inferred relationship | Some | ||
| Leuprorelin acetate 22.5 mg powder for prolonged-release suspension for injection vial | Has manufactured dose form | Powder for extended-release suspension for injection | true | Inferred relationship | Some | ||
| Leuprorelin acetate 22.5 mg powder for prolonged-release suspension for injection vial | Has unit of presentation | Vial | true | Inferred relationship | Some | ||
| Leuprorelin acetate 22.5 mg powder for prolonged-release suspension for injection vial | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Leuprorelin acetate 22.5 mg powder for prolonged-release suspension for injection vial | Has precise active ingredient | Leuprorelin acetate | true | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 22.5 mg powder for prolonged-release suspension for injection vial | Has BoSS | Leuprorelin acetate | true | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 22.5 mg powder for prolonged-release suspension for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 22.5 mg powder for prolonged-release suspension for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR